A time-course design (0–240 min) combined commercial papain versus bromelain treatment with UPLC-HRMS metabolite profiling to ...
MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) announced today the introduction of the ACQUITY™ UPLC PLUS Series, three new ACQUITY UltraPerformance LC™ (UPLC™) Systems that build off ...
Waters Corporation today announced the launch of the Waters omniDAWN ™ Multi-Angle Light Scattering (MALS) Photometer, part of the Wyatt Technology Portfolio. Featuring 18 angles of detection, the ...
ACQUITY™ Premier UPLC™ System: The next evolution in separation science is here. Maximizing the sensitivity, repeatability, and robustness of your LC and LC-MS applications is critical. The ACQUITY ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
The company’s next-generation ultraperformance liquid chromatography platform is designed to meet the evolving laboratory requirements for chromatographic performance. Waters’ Acquity ultraperformance ...
NEWARK, Del.--(BUSINESS WIRE)--#HRMS--QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials, and clinical research ...
Waters tells us, "The technology is adaptable and robust enough to bridge the HPLC and UPLC performance gap while continuing to support validated assays.” To learn more about this exciting development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results